Over 45 product categories, including nickel and pharmaceuticals, will see zero tariffs for partners with trade agreements.
Exemptions target goods not produced sufficiently in the U.S. while supporting strategic imports like EV materials and medical compounds.
The move aligns tariffs with negotiated deals, pressuring allies to commit to reciprocal trade terms.